Adult patients – Page 8 – Communicable Diseases Research

Diagnostic Significance of Serum Galectin-3 in Hospitalized Patients with COVID-19—A Preliminary Study

COVID-19를 가진 입원 환자에서 혈청 갈 렉틴 -3의 진단 적 중요성-예비 연구

Observational Study

Published on 2021-08-012022-09-10
Journal: Biomolecules [Category] MERS, 바이오마커, 임상,

Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19

COVID-19로 입원한 미국 재향 군인의 생존 및 입원 기간과 렘데시비르 치료의 연관성

Research

Published on 2021-07-152022-09-10
Journal: JAMA Network Open [Category] SARS, 치료제,

[키워드] 30-Day mortality 95% CI adjusted adjusted hazard ratio Admission Adult patients age Analysis association clinical trial Cohort cohort study competing Control control patient controls COVID-19 Cox proportional hazard Cox proportional hazards regression death Dexamethasone Effect exposure Final finding health administration hospital hospital discharge Hospital stay Hospitalization Hospitalized hospitals identify Importance improvement Improvements individuals initial initiated intensive care intensive care unit interquartile range laboratory-confirmed Laboratory-confirmed COVID-19 Length less log rank matched control matched controls measure Measures mechanical ventilation median time men objective outcome participant Patient people with COVID-19 Point Propensity score propensity score matching randomized clinical trials receiving recipient Relevance Remdesivir Result retrospective cohort study routine routine care setting Sex significant increase survival therapy time Treatment treatment initiation used data veteran was used were assessed with COVID-19
[DOI] 10.1001/jamanetworkopen.2021.14741 PMC 바로가기 [Article Type] Research

On-admission SARS-CoV-2 RNAemia as a single potent predictive marker of critical condition development and mortality in COVID-19

COVID-19에서 중요한 상태 발달 및 사망률의 단일 강력한 예측 마커로서의 공인 SARS-COV-2 RNAEMIA

Research Article

Published on 2021-07-132022-09-10
Journal: PLoS ONE [Category] SARS, 바이오마커, 진단,

Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study

COVID-19 환자의 중대 질환 다발신경병증, 근육병증 및 신경 바이오마커: 전향적 연구

Observational Study

Published on 2021-07-012022-09-11
Journal: Clinical neurophysiology : official journal of the [Category] MERS, 바이오마커, 임상, 진단,

[키워드] Acidic Adult patients amplitudes Biomarker Characteristics cohort study coronavirus disease Coronavirus disease 2019 correlated COVID-19 COVID-19 patient COVID-19 patients Critical Critical illness Critical illness neuropathy Critical illness polyneuropathy develop early phase feature GFAp had more ICU ICU care ICU patient ICU Patients intensive care intensive care unit invasive ventilation light chain Myopathy neurofilament neuronal Neuropathy NfL Non-COVID-19 non-COVID-19 cohort Patient plasma biomarker Polyneuropathy Predictive prevalent Prospective Study Protein SARS-CoV-2 significantly higher thromboembolic Thromboembolic event treated Uppsala Uppsala University weakness
[DOI] 10.1016/j.clinph.2021.03.016 PMC 바로가기 [Article Type] Observational Study

Different incidences of acute kidney injury (AKI) and outcomes in COVID-19 patients with and without non-azithromycin antibiotics: A retrospective study

비 아지스로마이신 항생제를 사용하거나 사용하지 않는 COVID-19 환자의 급성 신장 손상(AKI) 발생률 및 결과: 후향적 연구

Article

Published on 2021-07-012022-09-11
Journal: Journal of medical virology [Category] SARS, 치료제,

[키워드] 2019-nCoV 95% confidence interval acute kidney Acute kidney injury acute renal failure addition administration Admission Adult patients adverse events AKI angiotensin Angiotensin II angiotensin-converting enzyme inhibitor angiotensin-converting enzyme inhibitors Antibiotics association blockers caused Comorbidities Comorbidity concomitant infection conducted coronavirus disease Coronavirus disease 2019 Corticosteroid Corticosteroids COVID-19 COVID-19 patient criteria death determine diabete diabetes Effect evaluate the effect help Hospitalization hypertension ICU ICU admission incidence incidence rate indication indications initiated intensive care intensive care unit Kidney injury Lopinavir Lopinavir/ritonavir medication medications Mortality multivariable logistic regression nCoV Novel coronavirus Odds ratio outbreak outcome outcomes Participants Patient patients patients hospitalized poor prognosis Predictive Primary outcome receptor renal renal failure Retrospective study ribavirin Ritonavir SARS-CoV-2 secondary outcome severity was used with COVID-19
[DOI] 10.1002/jmv.26992 PMC 바로가기 [Article Type] Article

COVID-19 in Turkey: A tertiary center experience

터키의 COVID-19: 3차 센터 경험

Article

Published on 2021-07-012022-09-11
Journal: Pediatrics international : official journal of the [Category] SARS, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus addition Adult patients Azithromycin caused children clinical feature Combination Comorbidities Contact contact with coronavirus disease Coronavirus-2 country COVID-19 COVID-19 infection Critical D-dimer value diagnosed with COVID-19 disease Epidemic epidemiological Health health problem healthy Hydroxychloroquine Infection Invasive mechanical ventilation Laboratory lymphocyte Lymphocytes male median age Medical conditions Mild mild infection moderate non-invasive mechanical ventilation oseltamivir Patient radiological finding required SARS-CoV-2 SARS-CoV-2 virus Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 severe or critical illness the SARS-CoV-2 virus was used
[DOI] 10.1111/ped.14549 PMC 바로가기 [Article Type] Article

Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk

COVID-19 저산소 호흡기로 입원 한 환자에서 고용량 코르티코 스테로이드가있는 저용량 토 실리 주맙

Multicenter Study

Published on 2021-06-282022-09-01
Journal: The Annals of Pharmacotherapy [Category] MERS, 진단,

[키워드] 28-day mortality 95% CI Adult patients adult respiratory distress syndrome Analysis balance benefit Biomarker Combination combination therapies combination therapy Corticosteroid Corticosteroids COVID-19 COVID-19 pneumonia COVID-19 treatment Dexamethasone dexamethasone 6 mg dosage failure group hazard ratio high mortality hypoxia hypoxic respiratory failure Increased Infection Inflammation Interleukins medication therapy management Modification Mortality objective Patient patients with COVID-19 Pneumonia present reduction in mortality Relative risk Relevance respiratory Respiratory failure respiratory infections Result Retrospective study risk risk of infection Secondary infection severe respiratory failure Standard of care steroid supportive therapy survival therapeutic effect therapy Tocilizumab Treatment was performed were assessed
[DOI] 10.1177/10600280211028882 PMC 바로가기 [Article Type] Multicenter Study

Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial

COVID-19로 인한 저산소성 호흡 부전 환자에서 깨어 난 위치

Randomized Controlled Trial

Published on 2021-06-142022-08-13
Journal: Critical Care [Category] MERS, 임상,

[키워드] 30-Day mortality 95% CI Adult patient Adult patients adverse events assigned Awake prone positioning conducted control group COVID-19 Critical care did not reduce eligibility Endotracheal intubation Endpoint Enrollment futility groups High-flow nasal oxygen hospital hypoxemic Hypoxemic respiratory failure implemented protocol intensive care Intubated intubation intubation rate Intubation rates mechanical ventilation moderate to severe multicenter Noninvasive ventilation organ support oxygen PaO Patient patients with moderate per day pressure sore pressure sores primary endpoint prone group prone positioning protocol Randomized randomized clinical trial Randomly reduce respiratory Respiratory failure Respiratory Support Result secondary Secondary endpoints secondary outcome Secondary outcomes standard care supplementary material Trial Trial registration two patients Ventilator-free days
[DOI] 10.1186/s13054-021-03602-9 PMC 바로가기 [Article Type] Randomized Controlled Trial

Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression

혈청 보체 C3 및 C4 및 COVID-19 심각도 및 사망률: 메타 회귀를 사용한 체계적인 검토 및 메타 분석

Meta-Analysis

Published on 2021-06-072022-09-11
Journal: Frontiers in Immunology [Category] MERS, SARS, 바이오마커,

[키워드] 95% CI 95% confidence interval Activation Adult patients albumin Analysis blood cell C-reactive protein C3 C4 calculated certainty certainty of evidence CIs clinical consequence complement Complement activation Complement C3 complement components complement system components Concentration conducted Continuous data coronavirus coronavirus disease COVID-19 COVID-19 patient COVID-19 patients COVID-19 severity criteria CRP D-dimer direction disease severity effect size Egger’s tests eligibility criteria English language estimates evaluate Evidence GRADE heterogeneity magnitude measure Meta-analysis meta-regression moderate Mortality Newcastle-Ottawa Scale non-survivor Patient patients performed predict PROSPERO publication bias random-effects model Registration registration number Regression review searched sensitivity analysis serum serum concentrations severity significantly significantly lower SMD standardized mean difference study heterogeneity survival survivor systematic review Web of Science White blood cell white blood cell count
[DOI] 10.3389/fimmu.2021.696085 PMC 바로가기 [Article Type] Meta-Analysis

Lockdown, slow down: impact of the COVID-19 pandemic on physical activity—an observational study

잠금, 속도 : 신체 활동에 대한 Covid-19 Pandemic의 영향-관찰 연구

Observational Study

Published on 2021-06-042022-09-01
Journal: Open Heart [Category] MERS, SARS, 임상, 진단,